Strive, Inc. (ASST) entered a merger agreement on September 22, 2025, to acquire Semler Scientific, Inc. (SMLR) in a deal valued at $1.6 billion.
Each common share of Semler Scientific will be exchanged for 21.05 Class A common shares of Strive, representing a price of $90.52 per share. This is at a premium of 210.21% from the stock’s last close.
Semler Scientific is a Santa Clara, California–based medical technology company that develops and markets devices and software, including its FDA-cleared QuantaFlo test, for early detection and monitoring of chronic diseases, while also strategically holding Bitcoin as part of its treasury.
Strive is a Dallas-based asset management company and the first publicly traded firm to hold Bitcoin as its treasury, focused on growing Bitcoin per share, and through its subsidiary Strive Asset Management, manages over $2 billion in ETFs and investment portfolios.
The combined company would hold over 10,900 Bitcoin, in addition to sufficient cash reserves to support future perpetual preferred offerings, before any additional Bitcoin is raised through future financings.
In addition, Strive announced it bought 5,816 Bitcoin for its corporate treasury at an average price of $116,047 each, totaling $675 million, including fees, bringing its total Bitcoin holdings to 5,886.
Strive’s management and Board of Directors will remain in place after closing, with Semler Scientific Executive Chairman Eric Semler expected to join the combined company’s Board.
Semler Scientific received financial advice from LionTree Advisors, while Strive was advised financially by Cantor Fitzgerald.
Strive is acquiring Semler Scientific at 6.18 times its sales.
For a more comprehensive analysis of this merger and acquisition deal, please follow the link to the Deal Metrics page here:
Deal Metrics for the acquisition of Semler Scientific, Inc. (SMLR) by Strive, Inc. (ASST)
The Deal Metrics page provides a wealth of information, including:
Disclaimer: The information provided here is based on the data available at the time of publication. Readers are advised to conduct their own research and due diligence before engaging in any buying or selling activities involving the securities mentioned in this article. We do not guarantee the accuracy or completeness of this information.
Editor’s Note: Baranjot Kaur contributed to this article